Diagnosis and treatment of multiple sclerosis: a review
MP McGinley, CH Goldschmidt, AD Rae-Grant - Jama, 2021 - jamanetwork.com
Importance Multiple sclerosis (MS) is an autoimmune-mediated neurodegenerative disease
of the central nervous system characterized by inflammatory demyelination with axonal …
of the central nervous system characterized by inflammatory demyelination with axonal …
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
Cognitive and motor performance measures are commonly employed in multiple sclerosis
(MS) research, particularly when the purpose is to determine the efficacy of treatment. The …
(MS) research, particularly when the purpose is to determine the efficacy of treatment. The …
Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course
X Zhou, R Baumann, X Gao, M Mendoza, S Singh… - Cell, 2022 - cell.com
Changes in gut microbiota have been associated with several diseases. Here, the
International Multiple Sclerosis Microbiome Study (iMSMS) studied the gut microbiome of …
International Multiple Sclerosis Microbiome Study (iMSMS) studied the gut microbiome of …
Cognitive impairment in multiple sclerosis
ND Chiaravalloti, J DeLuca - The Lancet Neurology, 2008 - thelancet.com
Multiple sclerosis (MS) is a progressive disease of the CNS that is characterised by
widespread lesions in the brain and spinal cord. MS results in motor, cognitive, and …
widespread lesions in the brain and spinal cord. MS results in motor, cognitive, and …
[HTML][HTML] Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota
Multiple sclerosis (MS) is more common in western countries with diet being a potential
contributing factor. Here we show that intermittent fasting (IF) ameliorated clinical course and …
contributing factor. Here we show that intermittent fasting (IF) ameliorated clinical course and …
Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in …
S Meyer-Moock, YS Feng, M Maeurer, FW Dippel… - BMC neurology, 2014 - Springer
Background There are a number of instruments that describe severity and progression of
multiple sclerosis and they are increasingly used as endpoints to assess the effectiveness of …
multiple sclerosis and they are increasingly used as endpoints to assess the effectiveness of …
Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis
Abstract Background The Patient Determined Disease Steps (PDDS) is a promising patient-
reported outcome (PRO) of disability in multiple sclerosis (MS). To date, there is limited …
reported outcome (PRO) of disability in multiple sclerosis (MS). To date, there is limited …
Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting …
RK Burt, R Balabanov, J Burman, B Sharrack… - Jama, 2019 - jamanetwork.com
Importance Hematopoietic stem cell transplantation (HSCT) represents a potentially useful
approach to slow or prevent progressive disability in relapsing-remitting multiple sclerosis …
approach to slow or prevent progressive disability in relapsing-remitting multiple sclerosis …
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis
Clinically isolated syndromes (CIS), such as optic neuritis, brainstem or spinal cord
syndromes are frequently the first clinical presentations of multiple sclerosis. However, not …
syndromes are frequently the first clinical presentations of multiple sclerosis. However, not …
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) includes
representatives from advocacy organizations, Food and Drug Administration (FDA) …
representatives from advocacy organizations, Food and Drug Administration (FDA) …